NeoGenomics, Inc. Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings
NeoGenomics, Inc. (NEO) reported Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings · last filed 2022-02-25
- NeoGenomics, Inc. other-than-temporary impairment loss, debt securities, portion recognized in earnings for fiscal 2021 was $0.00.
- NeoGenomics, Inc. other-than-temporary impairment loss, debt securities, portion recognized in earnings for fiscal 2020 was $0.00.
- NeoGenomics, Inc. other-than-temporary impairment loss, debt securities, portion recognized in earnings for fiscal 2019 was $0.00.
| Period end | Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-25 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-25 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |